학술논문

Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia
Document Type
article
Source
American Journal of Medical Genetics Part A, vol 146A. (6)
Subject
Intellectual and Developmental Disabilities (IDD)
Neurodegenerative
Muscular Dystrophy
Dementia
Brain Disorders
Neurosciences
Genetics
Rare Diseases
Aging
Acquired Cognitive Impairment
2.1 Biological and endogenous factors
Aetiology
Neurological
Musculoskeletal
Adenosine Triphosphatases
Adult
Cell Cycle Proteins
Cross-Sectional Studies
Family
Female
Humans
Inclusion Bodies
Male
Middle Aged
Muscle
Skeletal
Muscular Diseases
Osteitis Deformans
Pedigree
Retrospective Studies
Valosin Containing Protein
autosomal dominant
hereditary inclusion body myopathy
limb-girdle muscular dystrophy
Paget disease of bone
frontotemporal dementia
chromosome 9p13.3-12
VCP
Clinical Sciences
Language
Abstract
Inclusion body myopathy with Paget disease of the bone (PDB) and/or frontotemporal dementia (IBMPFD, OMIM 167320), is a progressive autosomal dominant disorder caused by mutations in the Valousin-containing protein (VCP, p97 or CDC48) gene. IBMPFD can be difficult to diagnose. We assembled data on a large set of families to illustrate the number and type of misdiagnoses that occurred. Clinical analysis of 49 affected individuals in nine families indicated that 42 (87%) of individuals had muscle disease. The majority were erroneously diagnosed with limb girdle muscular dystrophy (LGMD), facioscapular muscular dystrophy, peroneal muscular dystrophy, late adult onset distal myopathy, spinal muscular atrophy, scapuloperoneal muscular dystrophy, or amyotrophic lateral sclerosis (ALS) among others. Muscle biopsies showed rimmed vacuoles characteristic of an inclusion body myopathy in 7 of 18 patients (39%), however, inclusion body myopathy was correctly diagnosed among individuals in only families 5 and 15. Frontotemporal dementia (FTD) was diagnosed in 13 individuals (27%) at a mean age of 57 years (range 48.9-60.2 years); however, several individuals had been diagnosed with Alzheimer disease. Histopathological examination of brains of three affected individuals revealed a pattern of ubiquitin positive neuronal intranuclear inclusions and dystrophic neurites. These families expand the clinical phenotype in IBMPFD, a complex disorder caused by mutations in VCP. The presence of PDB in 28 (57%) individuals suggests that measuring serum alkaline phosphatase (ALP) activity may be a useful screen for IBMPFD in patients with myopathy.